Percheron Therapeutics (PERCF) Ownership - Who Owns Percheron Therapeutics?
Percheron Therapeutics (PERCF) Ownership Overview
- 5.19% Insiders
- 94.81% Public Companies and Individual Investors
The ownership structure of Percheron Therapeutics (PERCF) stock is a mix of institutional, retail, and individual investors. , 5.19% is owned by Insiders, and 94.81% is owned by Public Companies and Individual Investors.
The ownership structure of Percheron Therapeutics (PERCF) stock is a mix of institutional, retail, and individual investors. Approximately 94.81% of the company’s stock is owned by Institutional Investors, 5.19% is owned by Insiders
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 14, 2026 | Michael Baker | AU$100,000 | |
| Apr 14, 2026 | James Garner | AU$107,000 | |
| Dec 29, 2025 | Ben Gil Price | AU$17,200 | |
| Dec 22, 2025 | James Garner | AU$8,500 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| James Garner | 74,900,000 | Insider | 3.78% | 749,000 |
| Michael Baker | 20,000,000 | Insider | 1.01% | 200,000 |
| Ben Gil Price | 7,999,805 | Insider | 0.40% | 79,998 |
FAQ
What percentage of Percheron Therapeutics (PERCF) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.81% of Percheron Therapeutics (PERCF) stock is held by retail investors.
Who owns the most shares of Percheron Therapeutics (PERCF)?
James Garner owns the most shares of Percheron Therapeutics (PERCF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.